These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21430646)

  • 1. Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys.
    Yamamoto S; Nishiyama S; Kawamata M; Ohba H; Wakuda T; Takei N; Tsukada H; Domino EF
    Neuropsychopharmacology; 2011 Jun; 36(7):1455-65. PubMed ID: 21430646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oxybutynin and imidafenacin on central muscarinic receptor occupancy and cognitive function: a monkey PET study with [(11)C](+)3-MPB.
    Yamamoto S; Maruyama S; Ito Y; Kawamata M; Nishiyama S; Ohba H; Yamada S; Tsukada H
    Neuroimage; 2011 Sep; 58(1):1-9. PubMed ID: 21712096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: a PET study in comparison with.
    Tsukada H; Takahashi K; Miura S; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Hatazawa J; Okudera T
    Synapse; 2001 Feb; 39(2):182-92. PubMed ID: 11180506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related changes in muscarinic cholinergic receptors in the living brain: a PET study using N-[11C]methyl-4-piperidyl benzilate combined with cerebral blood flow measurement in conscious monkeys.
    Kakiuchi T; Ohba H; Nishiyama S; Sato K; Harada N; Nakanishi S; Tsukada H
    Brain Res; 2001 Oct; 916(1-2):22-31. PubMed ID: 11597587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of reference tissue model of PET ligand [¹¹C]+3-MPB for the muscarinic cholinergic receptor in the living brain of conscious monkey.
    Yamamoto S; Ohba H; Nishiyama S; Takahashi K; Tsukada H
    Synapse; 2011 Jun; 65(6):548-51. PubMed ID: 21064187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomography.
    Yoshida A; Maruyama S; Fukumoto D; Tsukada H; Ito Y; Yamada S
    Life Sci; 2010 Jul; 87(5-6):175-80. PubMed ID: 20598326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scopolamine impairs auditory delayed matching-to-sample performance in monkeys.
    Plakke B; Ng CW; Poremba A
    Neurosci Lett; 2008 Jun; 438(1):126-30. PubMed ID: 18455309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzilate in the brains of conscious monkeys.
    Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Sato K; Harada N; Takahashi K
    Synapse; 2001 Sep; 41(3):248-57. PubMed ID: 11418938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of muscarinic cholinergic receptor ligands N-[11C]ethyl-4-piperidyl benzilate and N-[11C]propyl-4-piperidyl benzilate: a PET study in comparison with N-[11C]methyl-4-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Sato K; Harada N; Kakiuchi T; Tsukada H
    Nucl Med Biol; 2000 Nov; 27(8):733-40. PubMed ID: 11150704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor.
    Yamamoto S; Ouchi Y; Nakatsuka D; Tahara T; Mizuno K; Tajima S; Onoe H; Yoshikawa E; Tsukada H; Iwase M; Yamaguti K; Kuratsune H; Watanabe Y
    PLoS One; 2012; 7(12):e51515. PubMed ID: 23240035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptor occupancy by biperiden in living human brain.
    Sudo Y; Suhara T; Suzuki K; Okubo Y; Yoshikawa K; Uchida S; Sassa T; Okauchi T; Sasaki Y; Matsushita M
    Life Sci; 1999; 64(8):PL99-104. PubMed ID: 10069534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of
    Nabulsi NB; Holden D; Zheng MQ; Bois F; Lin SF; Najafzadeh S; Gao H; Ropchan J; Lara-Jaime T; Labaree D; Shirali A; Slieker L; Jesudason C; Barth V; Navarro A; Kant N; Carson RE; Huang Y
    J Nucl Med; 2019 Aug; 60(8):1147-1153. PubMed ID: 30733324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment.
    Klinkenberg I; Blokland A
    Psychopharmacology (Berl); 2011 Jun; 215(3):549-66. PubMed ID: 21336581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons.
    Varastet M; Brouillet E; Chavoix C; Prenant C; Crouzel C; Stulzaft O; Bottlaender M; Cayla J; Mazière B; Mazière M
    Eur J Pharmacol; 1992 Mar; 213(2):275-84. PubMed ID: 1521561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, restores the regional cerebral blood flow response abolished by scopolamine but not by HA-966: a positron emission tomography study with unanesthetized rhesus monkeys.
    Tsukada H; Yamazaki S; Noda A; Inoue T; Matsuoka N; Kakiuchi T; Nishiyama S; Nishimura S
    Brain Res; 1999 Jun; 832(1-2):118-23. PubMed ID: 10375657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
    J Neurosci; 2000 Sep; 20(18):7067-73. PubMed ID: 10995853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated ketamine administration produces up-regulation of muscarinic acetylcholine receptors in the forebrain, and reduces behavioral sensitivity to scopolamine in mice.
    Morita T; Hitomi S; Saito S; Fujita T; Uchihashi Y; Kuribara H
    Psychopharmacology (Berl); 1995 Feb; 117(4):396-402. PubMed ID: 7604139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey.
    Eddins D; Hamill TG; Puri V; Cannon CE; Vivian JA; Sanabria-Bohórquez SM; Cook JJ; Morrow JA; Thomson F; Uslaner JM
    Psychopharmacology (Berl); 2014 Feb; 231(3):511-9. PubMed ID: 24051602
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.